Publications:  Dr Shane Wilkinson

Francisco AF, Jayawardhana S, Olmo F, Lewis MD, Wilkinson SR, Taylor MC, Kelly JM(2020). Challenges in Chagas Disease Drug Development. Molecules vol. 25, (12) 2799-2799.

Dittani A, Wilkinson SR(2019). Deciphering the interstrand crosslink DNA repair network expressed by Trypanosoma brucei. DNA Repair vol. 78, 154-166.

Toro P, Suazo C, Acuña A, Fuentealba M, Artigas V, Arancibia R, Olea-Azar C, Moncada M et al.(2018). Cyrhetrenylaniline and new organometallic phenylimines derived from 4- and 5-nitrothiophene: Synthesis, characterization, X-Ray structures, electrochemistry and in vitro anti-T. brucei activity. Journal of Organometallic Chemistry vol. 862, 13-21.

Guerrero SA, Arias DG, Cabeza MS, Law MCY, D'Amico M, Kumar A, Wilkinson SR(2017). Functional characterization of the methionine sulfoxide reductase repertoire in Trypanosoma brucei. Free Radic Biol Med vol. 112, 524-533.

Meredith EL, Kumar A, Konno A, Szular J, Alsford A, Seifert K, Horn D, WILKINSON SR(2017). Distinct activation mechanisms trigger the trypanocidal activity of DNA damaging prodrugs. Molecular Microbiology vol. 106, (2) 207-222.

Ranzani AT, Nowicki C, WILKINSON SR, Cordeiro AT(2017). Identification of Specific Inhibitors of Trypanosoma cruzi Malic Enzyme Isoforms by Target-Based HTS. SLAS Discovery vol. 22, (9) 1150-1161.

de Padua RAP, Kia AM, Filho AJC, WILKINSON SR, Nonato MC(2017). Characterisation of the fumarate hydratase repertoire in Trypanosoma cruzi. International Journal of Biological Macromolecules vol. 102, 42-51.

Papadopoulou MV, Bloomer WD, Rosenzweig HS, Wilkinson SR, Szular J, Kaiser M(2016). Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity. European Journal of Medicinal Chemistry vol. 123, 895-904.

Papadopoulou MV, Bloomer WD, Rosenzweig HS, WILKINSON SR, Szular J, Kaiser M(2016). Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds. European Journal of Medicinal Chemistry vol. 117, 179-186.

O'Shea IP, Shahed M, Aguilera-Venegas B, WILKINSON SR(2016). Evaluating 5-nitrothiazoles as trypanocidal agents. Antimicrobial Agents and Chemotherapy vol. 60, (2) 1137-1140.

Papadopoulou MV, Bloomer WD, Rosenzweig HS, O'Shea IP, Wilkinson SR, Kaiser M(2015). 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents. European Journal of Medicinal Chemistry vol. 103, 325-334.

Papadopoulou MV, Bloomer WD, Rosenzweig HS, O¿Shea IP, Wilkinson SR, Kaiser M, Chatelain E, Ioset J-R(2015). Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation. Bioorganic & Medicinal Chemistry vol. 23, (19) 6467-6476.

Sullivan JA, Tong JL, Wong M, Kumar A, Sarkar H, Ali S, Hussein I, Zaman I et al.(2015). Unravelling the role of SNM1 in the DNA repair system of Trypanosoma brucei. Molecular Microbiology vol. 96, (4) 827-838.

Taylor MC, Lewis MD, Fortes-Francisco A, WILKINSON SR, Kelly JM(2015). The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence. PLoS Neglected Tropical Diseases vol. 9, (4)

Sullivan JA, Tong JL, Wong M, Kumar A, Sarkar H, Ali S, Hussein I, Zaman I et al.(2015). Unravelling the role of SNM1 in the DNA repair system of Trypanosoma brucei. Molecular Microbiology vol. 96, (4) 827-838.

Shameer S, Logan-Klumper F, Vinson F, Cottret L, Merlet B, Achcar F, Boshart M, Berriman M et al.(2015). TrypanoCyc: A community led biochemical pathways database for Trypanosoma brucei. Nucleic Acids Research vol. 43, D637-D644.

Papadopoulou MV, Bloomer WD, Lepesheva GI, Rosenzweig HS, Kaiser M, Aguilera-Venegas B, WILKINSON SR, Chatelain E et al.(2015). Novel 3-nitrotriazole-based amides and carbinols as bifunctional anti-Chagasic agents. Journal of Medicinal Chemistry vol. 58, (3) 1307-1319.

Papadopoulou MV, Bloomer WD, Rosenzweig HS, WILKINSON SR, Kaiser M(2014). Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents. European Journal of Medicinal Chemistry vol. 87, 79-88.

Carvalho AS, Salomão K, Castro SL, Conde TR, Silva Zamith HP, Caffarena ER, Hall BS, WILKINSON SR et al.(2014). Megazol and its bioisostere 4H-1,2,4-triazole: Comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the T. brucei nitroreductase enzyme (TbNTR). Memórias do Instituto Oswaldo Cruz vol. 109, (3) 315-323.

Voak AA, Seifert K, Helsby NA, WILKINSON SR(2014). Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugs. Antimicrobial Agents and Chemotherapy vol. 58, (1) 370-377.

Papadopoulou MV, Bloomer WD, Rosenzweig HS, Ashworth R, WILKINSON SR, Kaiser M, Andriani G, Rodriguez A(2013). Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: In vivo studies. Future Medicinal Chemistry vol. 5, (15) 1763-1776.

Roussaki M, Hall B, Lima SC, da Silva AC, Wilkinson S, Detsi A(2013). Synthesis and anti-parasitic activity of a novel quinolinylchalcones series. Bioorganic and Medicinal Chemistry Letters vol. 23, 6436-6441.

Voak AA, Gobalakrishnapillai V, Seifert K, Balczo E, Hu L, Hall BS, WILKINSON SR(2013). An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs. Journal of Biological Chemistry vol. 288, (40) 28466-28476.

Buchanan-Kilbey G, Djumpah J, Papadopoulou MV, Bloomer W, Hu L, WILKINSON SR, Ashworth R(2013). Evaluating the developmental toxicity of trypanocidal nitroaromatic compounds on zebrafish. Acta Tropica vol. 128, (3) 701-705.

Bot C, Hall BS, Alvarez G, Di Maio D, Gonzalez M, Cerecetto H, WILKINSON SR(2013). Evaluating 5-nitrofurans as trypanocidal agents. Antimicrobial Agents and Chemotherapy vol. 57, 1638-1647.

Kelly JM, WILKINSON SR(2013). Mechanisms of resistance to antiparasitic drugs in Trypanosoma cruzi. Is there a correlation between genotype and resistance?. Revista. Espanola de Salud Publica. vol. 87, 17-23.

Hall BS, Meredith EL, WILKINSON SR(2012). Targeting the substrate preference of a type I nitroreductase to develop anti-trypanosomal quinone-based prodrugs. Antimicrobial Agents and Chemotherapy vol. 56, (11) 5821-5830.

Papadopoulou MV, Bloomer WD, Rosenzweig HS, Chatelain E, Kaiser M, WILKINSON SR, McKenzie C, Ioset JR(2012). Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents. Journal of Medicinal Chemistry vol. 55, (11) 5554-5565.

Caminos AP, Panozzo-Zenere EA, WILKINSON SR, Tekwani BL, Labadie GR(2012). Synthesis and antikinetoplastid activity of a series of N,N'-substituted diamines. Bioorganic and Medicinal Chemistry Letters vol. 22, (4) 1712-1715.

Hall BS, Wilkinson SR(2012). Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation. Antimicrobial Agents and Chemotherapy vol. 56, (1) 115-123.

Mejia AM, Hall BS, Taylor MC, Gómez-Palacio A, WILKINSON SR, Triana-Chávez O, Kelly JM(2012). Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population. Journal of Infectious Diseases vol. 2, (206) 220-228.

Yang Y, Voak A, WILKINSON SR, Hu L(2012). Design, synthesis, and evaluation of potential prodrugs of DFMO for reductive activation. Bioorganic and Medicinal Chemistry Letters vol. 22, (21) 6583-6586.

Papadopoulou MV, Trunz BB, Bloomer WD, McKenzie C, WILKINSON SR, Prasittichai C, Brun R, Kaiser M et al.(2011). Novel 3-Nitro-1H-1,2,4-triazole-based Aliphatic and Aromatic Amines as anti-Chagasic Agents. Journal of Medicinal Chemistry vol. 54, (23) 8214-8223.

Hu L, Wu X, Han J, Chen L, Vass SO, Browne P, Hall BS, Bot C et al.(2011). Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs. Bioorg. Med. Chem. Lett vol. 21, 3986-3991.

Hall BS, Bot C, Wilkinson SR(2011). Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites. Journal of Biological Chemistry vol. 286, (15) 13088-13095.

Papadopoulou MV, Bloomer WD, Chatelain E, Kaiser M, Wilkinson SR, Ioset JR (2011). Novel nitrotriazole/imidazole-based amides and sulfonamides as potential anti-trypanosomal drugs, III. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. vol. 241,

Wilkinson SR, Bot C, Kelly JM, Hall BS(2011). Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives. Current Topics in Medicinal Chemistry vol. 11, (16) 2072-2084.

Sarell CJ, Wilkinson SR, Viles JH(2010). Substoichiometric levels of Cu2+ ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-{beta} from Alzheimer disease. Journal of Biological Chemistry vol. 285, (53) 41533-41540.

Bot C, Hall BS, Bashir N, Taylor MC, Helsby NA, Wilkinson SR(2010). Trypanocidal activity of aziridinyl nitrobenzamide prodrugs. Antimicrobial Agents and Chemotherapy vol. 54, (10) 4246-4252.

Hall BS, Wu X, Hu L, Wilkinson SR(2010). Exploiting the drug-activating properties of a novel trypanosomal nitroreductase. Antimicrobial Agents and Chemotherapy vol. 54, (3) 1193-1199.

Patel S, Hussain S, Harris R, Sardiwal S, Kelly JM, Wilkinson SR, Driscoll PC, Djordjevic S(2010). Structural insights into the catalytic mechanism of Trypanosoma cruzi GPXI (glutathione peroxidase-like enzyme I). Biochemical Journal vol. 425, 513-522.

Schnick C, Polley SD, Fivelman QL, Ranford-Cartwright LC, Wilkinson SR, Brannigan JA, Wilkinson AJ, Baker DA(2009). Structure and non-essential function of glycerol kinase in Plasmodium falciparum blood stages. Molecular Microbiology vol. 71, (2) 533-545.

Wilkinson SR, Kelly JM(2009). Trypanocidal drugs: mechanisms, resistance and new targets. Expert Reviews in Molecular Medicine vol. 11,

Irigoin F, Cibils L, Comini MA, Wilkinson SR, Flohe L, Radi R(2008). Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification. Free Radical Biology and Medicine vol. 45, (6) 733-742.

Wilkinson SR, Taylor MC, Horn D, Kelly JM, Cheeseman I(2008). A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proceedings of the National Academy of Sciences of USA vol. 105, (13) 5022-5027.

Piacenza L, Peluffo G, Alvarez MN, Kellyt JM, Wilkinsont SR, Radi R(2008). Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite. Biochemical Journal vol. 410, 359-368.

Taylor MC, Kaur H, Blessington B, Kelly JM, Wilkinson SR(2008). Validation of spermidine synthase as a drug target in African trypanosomes. Biochemical Journal vol. 409, (2) 563-569.

Logan FJ, Taylor MC, Wilkinson SR, Kaur H, Kelly JM(2007). The terminal step in vitamin C biosynthesis in Trypanosoma cruzi is mediated by a FMN-dependent galactonolactone oxidase. Biochemical Journal vol. 407, (3) 419-426.

Piacenza L, Irigoin F, Alvarez MN, Peluffo G, Taylor MC, Kelly JM, Wilkinson SR, Radi R(2007). Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression. Biochemical Journal vol. 403, 323-334.

Prathalingham SR, Wilkinson SR, Horn D, Kelly JM(2007). Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole. Antimicrobial Agents and Chemotherapy vol. 51, (2) 755-758.

Wilkinson SR, Prathalingam SR, Taylor MC, Ahmed A, Horn D, Kelly JM(2006). Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei. Free Radical Biology and Medicine vol. 40, (2) 198-209.

Wilkinson SR, Prathalingam SR, Taylor MC, Horn D, Kelly JM(2005). Vitamin C biosynthesis in trypanosomes: A role for the glycosome. P NATL ACAD SCI USA vol. 102, (33) 11645-11650.

Obado SO, Taylor MC, Wilkinson SR, Bromley EV, Kelly JM(2005). Functional mapping of a trypanosome centromere by chromosome fragmentation identifies a 16-kb GC-rich transcriptional "strand-switch" domain as a major feature. Genome Research vol. 15, (1) 36-43.

Bromley EV, Taylor MC, Wilkinson SR, Kelly JM(2004). The amino terminal domain of a novel WD repeat protein from Trypanosoma cruzi contains a non-canonical mitochondrial targeting signal (vol 34, pg 63, 2004). INT J PARASITOL vol. 34, (8) 989-989.

Bromley EV, Taylor MC, Wilkinson SR, Kelly JM(2004). The amino terminal domain of a novel WD repeat protein from Trypanosoma cruzi contains a non-canonical mitochondrial targeting signal. International Journal of Parasitology vol. 34, (1) 63-71.

Wilkinson SR, Horn D, Prathalingam SR, Kelly JM(2003). RNA interference identifies two hydroperoxide metabolizing enzymes that are essential to the bloodstream form of the African trypanosome. J BIOL CHEM vol. 278, (34) 31640-31646.

Wilkinson SR, Kelly JM(2003). The role of glutathione peroxidases in trypanosomatids. Biol Chem vol. 384, (4) 517-525.

Wilkinson SR, Obado SO, Mauricio IL, Kelly JM(2002). Trypanosoma cruzi expresses a plant-like ascorbate-dependent hemoperoxidase localized to the endoplasmic reticulum. Proc Natl Acad Sci U S A vol. 99, (21) 13453-13458.

Wilkinson SR, Taylor MC, Touitha S, Mauricio IL, Meyer DJ, Kelly JM(2002). TcGPXII, a glutathione-dependent Trypanosoma cruzi peroxidase with substrate specificity restricted to fatty acid and phospholipid hydroperoxides, is localized to the endoplasmic reticulum. BIOCHEM J vol. 364, 787-794.

Wilkinson SR, Meyer DJ, Taylor MC, Bromley EV, Miles MA, Kelly JM(2002). The Trypanosoma cruzi enzyme TcGPXI is a glycosomal peroxidase and can be linked to trypanothione reduction by glutathione or tryparedoxin. J Biol Chem vol. 277, (19) 17062-17071.

Wilkinson SR, Meyer DJ, Kelly JM(2000). Biochemical characterization of a trypanosome enzyme with glutathione-dependent peroxidase activity. BIOCHEM J vol. 352, 755-761.

Wilkinson SR, Temperton NJ, Mondragon A, Kelly JM(2000). Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi. J Biol Chem vol. 275, (11) 8220-8225.

Mondragon A, Wilkinson SR, Taylor MC, Kelly JM(1999). Optimization of conditions for growth of wild-type and genetically transformed Trypanosoma cruzi on agarose plates. PARASITOLOGY vol. 118, 461-467.

Temperton NJ, Wilkinson SR, Meyer DJ, Kelly JM(1998). Overexpression of superoxide dismutase in Trypanosoma cruzi results in increased sensitivity to the trypanocidal agents gentian violet and benznidazole. MOLECULAR AND BIOCHEMICAL PARASITOLOGY vol. 96, (1-2) 167-176.

Tovar J, Wilkinson S, Mottram JC, Fairlamb AH(1998). Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus. MOLECULAR MICROBIOLOGY vol. 29, (2) 653-660.

Temperton NJ, Wilkinson SR, Kelly JM(1996). Cloning of an Fe-superoxide dismutase gene homologue from Trypanosoma cruzi. MOLECULAR AND BIOCHEMICAL PARASITOLOGY vol. 76, (1-2) 339-343.